Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Cognition Therapeutics revenue
Cognition Therapeutics's revenue is $19.5 million.
What is Cognition Therapeutics's revenue?
- Cognition Therapeutics's revenue growth from 2022 to 2024 is -12.01%.
- Cognition Therapeutics has 30 employees, and the revenue per employee ratio is $651,633.
- Cognition Therapeutics's peak quarterly revenue was $3.0M in 2024(q4).
- Cognition Therapeutics peak revenue was $24.8M in 2023.
- Cognition Therapeutics annual revenue for 2023 was 24.8M, 11.65% growth from 2022.
- Cognition Therapeutics annual revenue for 2024 was 19.5M, -21.19% growth from 2023.
On this page
Zippia finds jobs where you're a top candidate and applies on your behalf.
Cognition Therapeutics historical revenue
Cognition Therapeutics annual revenue
Cognition Therapeutics annual revenue over time
| Fiscal year / year | Cognition Therapeutics revenue |
|---|---|
| 2022 | $22.2M |
| 2023 | $24.8M |
| 2024 | $19.5M |
Cognition Therapeutics jobs nearby
Do you work at Cognition Therapeutics?
Is Cognition Therapeutics transparent about its revenue structure?
Cognition Therapeutics financing
Cognition Therapeutics received early financing of $200.0K on 2007-11-27.
| Series | Round size | Date |
|---|---|---|
| Pre Seed | $200K | 11/2007 |
| Series Unknown | $400K | 05/2009 |
| Series A | $1.2M | 07/2009 |
| Series A | $2.5M | 01/2011 |
| Series Unknown | $1.8M | 12/2011 |
| Series Unknown | $2.5M | 12/2012 |
| Series B | $3M | 09/2013 |
| Series Unknown | $138K | 10/2013 |
| Series Unknown | $6.0M | 04/2014 |
| Series Unknown | $3.1M | 04/2015 |
| Series B | $15.8M | 07/2015 |
| Series B | $12M | 09/2015 |
| Convertible Note | $3.5M | 03/2016 |
| Series Unknown | $3M | 10/2016 |
| Grant | $6.6M | 05/2018 |
| Grant | $16.6M | 10/2018 |
| Grant | $3.3M | 07/2019 |
| Grant | $75.8M | 06/2020 |
Cognition Therapeutics investors
| Investors | Security type |
|---|---|
| New York Angels | Pre Seed |
| Pittsburgh Life Sciences Greenhouse | Pre Seed |
| Innovation Works | Series Unknown |
| Ogden Capital | Series A |
| Pittsburgh Life Sciences Greenhouse | Series A |
| Innovation Works | Series A |
| M5Invest Partners | Series A |
| Ogden Capital | Series A |
| Pittsburgh Life Sciences Greenhouse | Series A |
| Innovation Works | Series A |
| M5Invest Partners | Series A |
| Golden Seeds | Series A |
| Tech Coast Angels | Series A |
| TMC Investment Company | Series A |
| Pittsburgh Life Sciences Greenhouse | Series Unknown |
| Innovation Works | Series Unknown |
| Accelerator Fund | Series Unknown |
| Pittsburgh Life Sciences Greenhouse | Series Unknown |
| Maine Angels | Series Unknown |
| Dolby Family Ventures | Series B |
| BlueTree Allied Angels | Series B |
| Scale Investors | Series B |
| Ogden Capital | Series B |
| Dolby Family Ventures | Series B |
| Maine Angels | Series B |
| Accelerator Fund | Series B |
| M5Invest Partners | Series B |
| Golden Seeds | Series B |
| Tech Coast Angels | Series B |
| Cowtown Angels | Series B |
| Ariel Southeast Angel Partners | Series B |
| Sofia Fund | Convertible Note |
| Maine Angels | Series Unknown |
| Sofia Fund | Series Unknown |
| National Institute on Aging | Grant |
| National Institute on Aging | Grant |
| National Institute on Aging | Grant |
Cognition Therapeutics revenue FAQs
Search for jobs
Most in demand jobs
Zippia gives an in-depth look into the details of Cognition Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Cognition Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at Cognition Therapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Cognition Therapeutics. The data presented on this page does not represent the view of Cognition Therapeutics and its employees or that of Zippia.
Cognition Therapeutics may also be known as or be related to COGNITION THERAPEUTICS, COGNITION THERAPEUTICS INC, Cognition Therapeutics, Cognition Therapeutics Inc and Cognition Therapeutics, Inc.